Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years

A genetic component of early-onset lung cancer has been suggested. The role of metabolic gene polymorphisms has never been studied in young lung cancer cases. Phase 1 and Phase 2 gene polymorphisms are involved in tobacco carcinogens' metabolism and therefore in lung cancer risk. The effect of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of epidemiology 2003-02, Vol.32 (1), p.60-63
Hauptverfasser: TAIOLI, E, GASPARI, L, HIRVONEN, A, HUSGAFVEL-PURSIAINEN, K, KALINA, I, KREMERS, P, LE MARCHAND, L, LONDON, S, RANNUG, A, ROMKES, M, SCHOKET, B, SEIDEGARD, J, BENHAMOU, S, STRANGE, R. C, STACKER, I, TO-FIGUERAS, J, GARTE, S, BOFFETTA, P, BROCKMOLLER, J, BUTKIEWICZ, D, CASCORBI, I, CLAPPER, M. L, DOLZAN, V, HAUGEN, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 63
container_issue 1
container_start_page 60
container_title International journal of epidemiology
container_volume 32
creator TAIOLI, E
GASPARI, L
HIRVONEN, A
HUSGAFVEL-PURSIAINEN, K
KALINA, I
KREMERS, P
LE MARCHAND, L
LONDON, S
RANNUG, A
ROMKES, M
SCHOKET, B
SEIDEGARD, J
BENHAMOU, S
STRANGE, R. C
STACKER, I
TO-FIGUERAS, J
GARTE, S
BOFFETTA, P
BROCKMOLLER, J
BUTKIEWICZ, D
CASCORBI, I
CLAPPER, M. L
DOLZAN, V
HAUGEN, A
description A genetic component of early-onset lung cancer has been suggested. The role of metabolic gene polymorphisms has never been studied in young lung cancer cases. Phase 1 and Phase 2 gene polymorphisms are involved in tobacco carcinogens' metabolism and therefore in lung cancer risk. The effect of metabolic gene polymorphisms on lung cancer at young ages was studied by pooling data from the Genetic Susceptibility to Environmental Carcinogens (GSEC) database. All primary lung cancer cases of both sexes who were Caucasian and
doi_str_mv 10.1093/ije/dyg001
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_590241</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>345534571</sourcerecordid><originalsourceid>FETCH-LOGICAL-c586t-bde738f0514b2e83fd04c10f29da8ecb291685b22ba93bc673b75c6fd39ee45d3</originalsourceid><addsrcrecordid>eNp1kc-LEzEUx4Mobl29-AdIELzIjpuXZDKTYym6K1R2wXrwFJLJm3bq_OgmHZf-96bM4OLBw-Ml4ZPPI_kS8hbYJ2BaXDd7vPanLWPwjCxAKpkJVebPyYIJxrK8KOCCvIpxnwAppX5JLoArnXZsQe7uh_bUDeGwa2IXadPT1c97WMIVvfm--Ta1DVDbe9qO_ZZWtq8wUIft8EiPO6R2i3SoqczpCW2Ir8mL2rYR38z9kvz48nmzus3WdzdfV8t1VuWlOmbOYyHKmuUgHcdS1J7JCljNtbclVo5rSE9wnDurhatUIVyRV6r2QiPK3ItLkk3e-IiH0ZlDaDobTmawjZmPfqUVmlwzLiHx6__y7XhI5VKdLzCZC-2VMliq0kiuaqO9RwOFBCiVAytZ0l1Nup1t_3HdLtem6SOGzjDGlSoL_vs8_f2EH8LwMGI8mv0whj59kOGgIQeliwR9nKAqDDEGrP-KgZlz0CYFbaagE_xuNo6uQ_-Ezskm4MMM2FjZtg4puCY-cfLMSS7-AMPrrOg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219151697</pqid></control><display><type>article</type><title>Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><source>SWEPUB Freely available online</source><creator>TAIOLI, E ; GASPARI, L ; HIRVONEN, A ; HUSGAFVEL-PURSIAINEN, K ; KALINA, I ; KREMERS, P ; LE MARCHAND, L ; LONDON, S ; RANNUG, A ; ROMKES, M ; SCHOKET, B ; SEIDEGARD, J ; BENHAMOU, S ; STRANGE, R. C ; STACKER, I ; TO-FIGUERAS, J ; GARTE, S ; BOFFETTA, P ; BROCKMOLLER, J ; BUTKIEWICZ, D ; CASCORBI, I ; CLAPPER, M. L ; DOLZAN, V ; HAUGEN, A</creator><creatorcontrib>TAIOLI, E ; GASPARI, L ; HIRVONEN, A ; HUSGAFVEL-PURSIAINEN, K ; KALINA, I ; KREMERS, P ; LE MARCHAND, L ; LONDON, S ; RANNUG, A ; ROMKES, M ; SCHOKET, B ; SEIDEGARD, J ; BENHAMOU, S ; STRANGE, R. C ; STACKER, I ; TO-FIGUERAS, J ; GARTE, S ; BOFFETTA, P ; BROCKMOLLER, J ; BUTKIEWICZ, D ; CASCORBI, I ; CLAPPER, M. L ; DOLZAN, V ; HAUGEN, A</creatorcontrib><description>A genetic component of early-onset lung cancer has been suggested. The role of metabolic gene polymorphisms has never been studied in young lung cancer cases. Phase 1 and Phase 2 gene polymorphisms are involved in tobacco carcinogens' metabolism and therefore in lung cancer risk. The effect of metabolic gene polymorphisms on lung cancer at young ages was studied by pooling data from the Genetic Susceptibility to Environmental Carcinogens (GSEC) database. All primary lung cancer cases of both sexes who were Caucasian and &lt;/=45 years of age at diagnosis, and the corresponding controls were selected. We obtained 261 cases and 1452 controls. There was a marginally significant association between lung cancer and GSTT1 null genotype (OR=1.2; 95% CI:1.0-1.6), and a significant association between lung cancer and the homozygous CYP1A1 Msp1 variant allele (CYP1A1*2A and *2B) genotype (OR=4.7 95% CI:1.2-19.0). When data were stratified by smoking status, the association between CYP1A1 genotype and lung cancer was confined to never smokers. These results suggest that metabolic genetic factors play a role in lung cancer developing at young ages.</description><identifier>ISSN: 0300-5771</identifier><identifier>ISSN: 1464-3685</identifier><identifier>EISSN: 1464-3685</identifier><identifier>DOI: 10.1093/ije/dyg001</identifier><identifier>PMID: 12690010</identifier><identifier>CODEN: IJEPBF</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Age of Onset ; Biological and medical sciences ; Case-Control Studies ; Chi-Square Distribution ; Cytochrome P-450 CYP1A1 ; Cytochrome P-450 CYP1A1 - genetics ; Databases, Factual ; Factor Analysis, Statistical ; Female ; Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi ; Genetic Predisposition to Disease ; Glutathione Transferase ; Glutathione Transferase - genetics ; Health Sciences ; Humans ; Hälsovetenskap ; Life Sciences ; Lung Neoplasms ; Lung Neoplasms - genetics ; Male ; Medical and Health Sciences ; Medical sciences ; Medicin och hälsovetenskap ; Pneumology ; Polymorphism, Genetic ; Public Health, Global Health, Social Medicine and Epidemiology ; Risk Factors ; Santé publique et épidémiologie ; Smoking ; Smoking - adverse effects ; Tumors of the respiratory system and mediastinum</subject><ispartof>International journal of epidemiology, 2003-02, Vol.32 (1), p.60-63</ispartof><rights>2003 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Feb 2003</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c586t-bde738f0514b2e83fd04c10f29da8ecb291685b22ba93bc673b75c6fd39ee45d3</citedby><cites>FETCH-LOGICAL-c586t-bde738f0514b2e83fd04c10f29da8ecb291685b22ba93bc673b75c6fd39ee45d3</cites><orcidid>0000-0003-4911-5290</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,550,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14690042$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12690010$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inserm.hal.science/inserm-00266872$$DView record in HAL$$Hfree_for_read</backlink><backlink>$$Uhttps://lup.lub.lu.se/record/313041$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:1957682$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>TAIOLI, E</creatorcontrib><creatorcontrib>GASPARI, L</creatorcontrib><creatorcontrib>HIRVONEN, A</creatorcontrib><creatorcontrib>HUSGAFVEL-PURSIAINEN, K</creatorcontrib><creatorcontrib>KALINA, I</creatorcontrib><creatorcontrib>KREMERS, P</creatorcontrib><creatorcontrib>LE MARCHAND, L</creatorcontrib><creatorcontrib>LONDON, S</creatorcontrib><creatorcontrib>RANNUG, A</creatorcontrib><creatorcontrib>ROMKES, M</creatorcontrib><creatorcontrib>SCHOKET, B</creatorcontrib><creatorcontrib>SEIDEGARD, J</creatorcontrib><creatorcontrib>BENHAMOU, S</creatorcontrib><creatorcontrib>STRANGE, R. C</creatorcontrib><creatorcontrib>STACKER, I</creatorcontrib><creatorcontrib>TO-FIGUERAS, J</creatorcontrib><creatorcontrib>GARTE, S</creatorcontrib><creatorcontrib>BOFFETTA, P</creatorcontrib><creatorcontrib>BROCKMOLLER, J</creatorcontrib><creatorcontrib>BUTKIEWICZ, D</creatorcontrib><creatorcontrib>CASCORBI, I</creatorcontrib><creatorcontrib>CLAPPER, M. L</creatorcontrib><creatorcontrib>DOLZAN, V</creatorcontrib><creatorcontrib>HAUGEN, A</creatorcontrib><title>Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years</title><title>International journal of epidemiology</title><addtitle>Int J Epidemiol</addtitle><description>A genetic component of early-onset lung cancer has been suggested. The role of metabolic gene polymorphisms has never been studied in young lung cancer cases. Phase 1 and Phase 2 gene polymorphisms are involved in tobacco carcinogens' metabolism and therefore in lung cancer risk. The effect of metabolic gene polymorphisms on lung cancer at young ages was studied by pooling data from the Genetic Susceptibility to Environmental Carcinogens (GSEC) database. All primary lung cancer cases of both sexes who were Caucasian and &lt;/=45 years of age at diagnosis, and the corresponding controls were selected. We obtained 261 cases and 1452 controls. There was a marginally significant association between lung cancer and GSTT1 null genotype (OR=1.2; 95% CI:1.0-1.6), and a significant association between lung cancer and the homozygous CYP1A1 Msp1 variant allele (CYP1A1*2A and *2B) genotype (OR=4.7 95% CI:1.2-19.0). When data were stratified by smoking status, the association between CYP1A1 genotype and lung cancer was confined to never smokers. These results suggest that metabolic genetic factors play a role in lung cancer developing at young ages.</description><subject>Adult</subject><subject>Age of Onset</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Chi-Square Distribution</subject><subject>Cytochrome P-450 CYP1A1</subject><subject>Cytochrome P-450 CYP1A1 - genetics</subject><subject>Databases, Factual</subject><subject>Factor Analysis, Statistical</subject><subject>Female</subject><subject>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</subject><subject>Genetic Predisposition to Disease</subject><subject>Glutathione Transferase</subject><subject>Glutathione Transferase - genetics</subject><subject>Health Sciences</subject><subject>Humans</subject><subject>Hälsovetenskap</subject><subject>Life Sciences</subject><subject>Lung Neoplasms</subject><subject>Lung Neoplasms - genetics</subject><subject>Male</subject><subject>Medical and Health Sciences</subject><subject>Medical sciences</subject><subject>Medicin och hälsovetenskap</subject><subject>Pneumology</subject><subject>Polymorphism, Genetic</subject><subject>Public Health, Global Health, Social Medicine and Epidemiology</subject><subject>Risk Factors</subject><subject>Santé publique et épidémiologie</subject><subject>Smoking</subject><subject>Smoking - adverse effects</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>0300-5771</issn><issn>1464-3685</issn><issn>1464-3685</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>D8T</sourceid><recordid>eNp1kc-LEzEUx4Mobl29-AdIELzIjpuXZDKTYym6K1R2wXrwFJLJm3bq_OgmHZf-96bM4OLBw-Ml4ZPPI_kS8hbYJ2BaXDd7vPanLWPwjCxAKpkJVebPyYIJxrK8KOCCvIpxnwAppX5JLoArnXZsQe7uh_bUDeGwa2IXadPT1c97WMIVvfm--Ta1DVDbe9qO_ZZWtq8wUIft8EiPO6R2i3SoqczpCW2Ir8mL2rYR38z9kvz48nmzus3WdzdfV8t1VuWlOmbOYyHKmuUgHcdS1J7JCljNtbclVo5rSE9wnDurhatUIVyRV6r2QiPK3ItLkk3e-IiH0ZlDaDobTmawjZmPfqUVmlwzLiHx6__y7XhI5VKdLzCZC-2VMliq0kiuaqO9RwOFBCiVAytZ0l1Nup1t_3HdLtem6SOGzjDGlSoL_vs8_f2EH8LwMGI8mv0whj59kOGgIQeliwR9nKAqDDEGrP-KgZlz0CYFbaagE_xuNo6uQ_-Ezskm4MMM2FjZtg4puCY-cfLMSS7-AMPrrOg</recordid><startdate>20030201</startdate><enddate>20030201</enddate><creator>TAIOLI, E</creator><creator>GASPARI, L</creator><creator>HIRVONEN, A</creator><creator>HUSGAFVEL-PURSIAINEN, K</creator><creator>KALINA, I</creator><creator>KREMERS, P</creator><creator>LE MARCHAND, L</creator><creator>LONDON, S</creator><creator>RANNUG, A</creator><creator>ROMKES, M</creator><creator>SCHOKET, B</creator><creator>SEIDEGARD, J</creator><creator>BENHAMOU, S</creator><creator>STRANGE, R. C</creator><creator>STACKER, I</creator><creator>TO-FIGUERAS, J</creator><creator>GARTE, S</creator><creator>BOFFETTA, P</creator><creator>BROCKMOLLER, J</creator><creator>BUTKIEWICZ, D</creator><creator>CASCORBI, I</creator><creator>CLAPPER, M. L</creator><creator>DOLZAN, V</creator><creator>HAUGEN, A</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><general>Oxford University Press (OUP)</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T2</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>1XC</scope><scope>ADTPV</scope><scope>AGCHP</scope><scope>AOWAS</scope><scope>D8T</scope><scope>D95</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0003-4911-5290</orcidid></search><sort><creationdate>20030201</creationdate><title>Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years</title><author>TAIOLI, E ; GASPARI, L ; HIRVONEN, A ; HUSGAFVEL-PURSIAINEN, K ; KALINA, I ; KREMERS, P ; LE MARCHAND, L ; LONDON, S ; RANNUG, A ; ROMKES, M ; SCHOKET, B ; SEIDEGARD, J ; BENHAMOU, S ; STRANGE, R. C ; STACKER, I ; TO-FIGUERAS, J ; GARTE, S ; BOFFETTA, P ; BROCKMOLLER, J ; BUTKIEWICZ, D ; CASCORBI, I ; CLAPPER, M. L ; DOLZAN, V ; HAUGEN, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c586t-bde738f0514b2e83fd04c10f29da8ecb291685b22ba93bc673b75c6fd39ee45d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Age of Onset</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Chi-Square Distribution</topic><topic>Cytochrome P-450 CYP1A1</topic><topic>Cytochrome P-450 CYP1A1 - genetics</topic><topic>Databases, Factual</topic><topic>Factor Analysis, Statistical</topic><topic>Female</topic><topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic><topic>Genetic Predisposition to Disease</topic><topic>Glutathione Transferase</topic><topic>Glutathione Transferase - genetics</topic><topic>Health Sciences</topic><topic>Humans</topic><topic>Hälsovetenskap</topic><topic>Life Sciences</topic><topic>Lung Neoplasms</topic><topic>Lung Neoplasms - genetics</topic><topic>Male</topic><topic>Medical and Health Sciences</topic><topic>Medical sciences</topic><topic>Medicin och hälsovetenskap</topic><topic>Pneumology</topic><topic>Polymorphism, Genetic</topic><topic>Public Health, Global Health, Social Medicine and Epidemiology</topic><topic>Risk Factors</topic><topic>Santé publique et épidémiologie</topic><topic>Smoking</topic><topic>Smoking - adverse effects</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TAIOLI, E</creatorcontrib><creatorcontrib>GASPARI, L</creatorcontrib><creatorcontrib>HIRVONEN, A</creatorcontrib><creatorcontrib>HUSGAFVEL-PURSIAINEN, K</creatorcontrib><creatorcontrib>KALINA, I</creatorcontrib><creatorcontrib>KREMERS, P</creatorcontrib><creatorcontrib>LE MARCHAND, L</creatorcontrib><creatorcontrib>LONDON, S</creatorcontrib><creatorcontrib>RANNUG, A</creatorcontrib><creatorcontrib>ROMKES, M</creatorcontrib><creatorcontrib>SCHOKET, B</creatorcontrib><creatorcontrib>SEIDEGARD, J</creatorcontrib><creatorcontrib>BENHAMOU, S</creatorcontrib><creatorcontrib>STRANGE, R. C</creatorcontrib><creatorcontrib>STACKER, I</creatorcontrib><creatorcontrib>TO-FIGUERAS, J</creatorcontrib><creatorcontrib>GARTE, S</creatorcontrib><creatorcontrib>BOFFETTA, P</creatorcontrib><creatorcontrib>BROCKMOLLER, J</creatorcontrib><creatorcontrib>BUTKIEWICZ, D</creatorcontrib><creatorcontrib>CASCORBI, I</creatorcontrib><creatorcontrib>CLAPPER, M. L</creatorcontrib><creatorcontrib>DOLZAN, V</creatorcontrib><creatorcontrib>HAUGEN, A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>SwePub</collection><collection>SWEPUB Lunds universitet full text</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Lunds universitet</collection><collection>SwePub Articles full text</collection><jtitle>International journal of epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TAIOLI, E</au><au>GASPARI, L</au><au>HIRVONEN, A</au><au>HUSGAFVEL-PURSIAINEN, K</au><au>KALINA, I</au><au>KREMERS, P</au><au>LE MARCHAND, L</au><au>LONDON, S</au><au>RANNUG, A</au><au>ROMKES, M</au><au>SCHOKET, B</au><au>SEIDEGARD, J</au><au>BENHAMOU, S</au><au>STRANGE, R. C</au><au>STACKER, I</au><au>TO-FIGUERAS, J</au><au>GARTE, S</au><au>BOFFETTA, P</au><au>BROCKMOLLER, J</au><au>BUTKIEWICZ, D</au><au>CASCORBI, I</au><au>CLAPPER, M. L</au><au>DOLZAN, V</au><au>HAUGEN, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years</atitle><jtitle>International journal of epidemiology</jtitle><addtitle>Int J Epidemiol</addtitle><date>2003-02-01</date><risdate>2003</risdate><volume>32</volume><issue>1</issue><spage>60</spage><epage>63</epage><pages>60-63</pages><issn>0300-5771</issn><issn>1464-3685</issn><eissn>1464-3685</eissn><coden>IJEPBF</coden><abstract>A genetic component of early-onset lung cancer has been suggested. The role of metabolic gene polymorphisms has never been studied in young lung cancer cases. Phase 1 and Phase 2 gene polymorphisms are involved in tobacco carcinogens' metabolism and therefore in lung cancer risk. The effect of metabolic gene polymorphisms on lung cancer at young ages was studied by pooling data from the Genetic Susceptibility to Environmental Carcinogens (GSEC) database. All primary lung cancer cases of both sexes who were Caucasian and &lt;/=45 years of age at diagnosis, and the corresponding controls were selected. We obtained 261 cases and 1452 controls. There was a marginally significant association between lung cancer and GSTT1 null genotype (OR=1.2; 95% CI:1.0-1.6), and a significant association between lung cancer and the homozygous CYP1A1 Msp1 variant allele (CYP1A1*2A and *2B) genotype (OR=4.7 95% CI:1.2-19.0). When data were stratified by smoking status, the association between CYP1A1 genotype and lung cancer was confined to never smokers. These results suggest that metabolic genetic factors play a role in lung cancer developing at young ages.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>12690010</pmid><doi>10.1093/ije/dyg001</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-4911-5290</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0300-5771
ispartof International journal of epidemiology, 2003-02, Vol.32 (1), p.60-63
issn 0300-5771
1464-3685
1464-3685
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_590241
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection; SWEPUB Freely available online
subjects Adult
Age of Onset
Biological and medical sciences
Case-Control Studies
Chi-Square Distribution
Cytochrome P-450 CYP1A1
Cytochrome P-450 CYP1A1 - genetics
Databases, Factual
Factor Analysis, Statistical
Female
Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi
Genetic Predisposition to Disease
Glutathione Transferase
Glutathione Transferase - genetics
Health Sciences
Humans
Hälsovetenskap
Life Sciences
Lung Neoplasms
Lung Neoplasms - genetics
Male
Medical and Health Sciences
Medical sciences
Medicin och hälsovetenskap
Pneumology
Polymorphism, Genetic
Public Health, Global Health, Social Medicine and Epidemiology
Risk Factors
Santé publique et épidémiologie
Smoking
Smoking - adverse effects
Tumors of the respiratory system and mediastinum
title Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T07%3A44%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polymorphisms%20in%20CYP1A1,%20GSTM1,%20GSTT1%20and%20lung%20cancer%20below%20the%20age%20of%2045%20years&rft.jtitle=International%20journal%20of%20epidemiology&rft.au=TAIOLI,%20E&rft.date=2003-02-01&rft.volume=32&rft.issue=1&rft.spage=60&rft.epage=63&rft.pages=60-63&rft.issn=0300-5771&rft.eissn=1464-3685&rft.coden=IJEPBF&rft_id=info:doi/10.1093/ije/dyg001&rft_dat=%3Cproquest_swepu%3E345534571%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=219151697&rft_id=info:pmid/12690010&rfr_iscdi=true